News & Partnerships
Write-ups from the Phi team and the partnerships Phi's designs are built with.
News · September 21, 2026
Claude-optimized models on Phi
Anthropic's optimized protein models were running on Phi the morning after release. Here is how they measure on a production cluster.
Read the write-up →
News · March 18, 2026
Dyno Psi-1: Flexible de novo design with test-time scaling
Dyno's open miniprotein binder design model, with a yeast display assay that shows its hit rate scaling with more computational screening.
About Dyno Psi-1 →
Partnership · July 22, 2026
Closed loop modeling and experimentation
Phi's loop closes on measurements. Dyno is a founding member of the Atlas Consortium, which pools standardized experimental antibody-antigen data from A-Alpha Bio's AlphaSeq platform across its members for training and benchmarking design models.
Read the announcement →
Partnership
Gene delivery
Pair your therapeutic designs with best-in-class delivery. Dyno's capsids reach the brain, eye and muscle.
dynotx.com/gene-delivery →
Partnership
Dyno Frontiers and partnerships
Partnerships are Dyno's business, from capsid licensing to AI products like Phi and research collaborations. The Dyno Frontiers Network supports gene therapy developers advancing genetic payloads, connecting them to Dyno capsids, manufacturing and service partners, and investors.
dynotx.com/partnerships →